Feature Channels: Dermatology

Filters close
2-Nov-2022 10:15 AM EDT
Managing Eczema in Babies: Five Things to Know
McMaster University

Five key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.

Released: 3-Nov-2022 11:05 AM EDT
New ‘smart tattoos’ tackle tech challenges of on-skin computing
Cornell University

Researchers at Cornell University have come up with a reliable, skin-tight computing system that’s easy to attach and detach, and can be used for a variety of purposes – from health monitoring to fashion.

Released: 3-Nov-2022 11:00 AM EDT
MD Anderson Research Highlights for November 3, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

   
Released: 2-Nov-2022 11:30 AM EDT
American College of Rheumatology Educating Dermatologists and Nephrologists on Lupus Clinical Trials Racial Disparities
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.

Released: 2-Nov-2022 10:50 AM EDT
Diabetes and Your Skin
American Academy of Dermatology

Your skin is a window to your overall health, and what happens on your skin is often an indicator of what’s happening inside your body.

Newswise: Reprogramming of Immune Cells Shown to Fight Off Melanoma
Released: 31-Oct-2022 8:05 AM EDT
Reprogramming of Immune Cells Shown to Fight Off Melanoma
University of Bristol

A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma.

Newswise:Video Embedded how-to-treat-eczema-at-home
VIDEO
Released: 27-Oct-2022 1:30 PM EDT
How to Treat Eczema at Home
American Academy of Dermatology

ROSEMONT, Ill. (October 27, 2022) — Eczema, or atopic dermatitis, is a common skin condition affecting 1 in 10 Americans. Patients with eczema often experience itchy, dry, raw, and sensitive patches of skin, which greatly impacts their quality of life. As we wrap up Eczema Awareness Month, board-certified dermatologists provide easy steps you can take at home to ease your symptoms.

25-Oct-2022 11:00 AM EDT
Neoadjuvant Immunotherapy with Relatlimab and Nivolumab Is Safe and Effective in Stage III Melanoma
University of Texas MD Anderson Cancer Center

Giving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma before surgery was safe and completely cleared all viable tumor in 57% of patients in a Phase II study, researchers from The University of Texas MD Anderson Cancer Center reported in Nature.

Released: 25-Oct-2022 10:30 AM EDT
National Healthy Skin Month: Dermatologists Provide Tips on Caring for Your Skin, Hair, and Nails
American Academy of Dermatology

In recognition of National Healthy Skin Month in November, board-certified dermatologists are providing their top tips for caring for your skin, hair, and nails.

Released: 24-Oct-2022 3:55 PM EDT
Phase II clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer
Wiley

Numerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system’s response against various cancers.

Released: 20-Oct-2022 10:35 AM EDT
Single-Port Robotic Surgery Improves Patient Ratings of Scarring After Urologic Procedures
Wolters Kluwer Health: Lippincott

The use of next-generation, single-port surgical robots leads to improved cosmetic outcomes and patient perceptions of scarring after robotic kidney, bladder, or prostate surgery, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).

Released: 19-Oct-2022 12:00 PM EDT
MD Anderson Research Highlights for October 19, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a combination approach to overcome PARP inhibitor resistance in breast and ovarian cancers, a deeper understanding of STAT3 mutations as drivers of disease progression, insights into the “obesity paradox” in men with advanced melanoma, a prognostic model for rapidly progressing vestibular schwannoma, and a role for cellular trafficking proteins in creating a metastasis-promoting lung cancer microenvironment.

   
Newswise: 54 Mercy Medical Center Physicians Named Among Region's
Released: 19-Oct-2022 11:05 AM EDT
54 Mercy Medical Center Physicians Named Among Region's "TOP DOCTORS" in November 2022 Issue of BALTIMORE Magazine
Mercy Medical Center

A total of 54 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2022 “Top Doctors” issue, representing 28 separate specialties.

Released: 18-Oct-2022 11:05 AM EDT
Psoriasis does not appear to increase heart attack risk in people with significant kidney disease
Medical College of Georgia at Augusta University

Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.

Newswise: Chemist examines properties of tattoo inks
Released: 17-Oct-2022 2:05 PM EDT
Chemist examines properties of tattoo inks
Binghamton University, State University of New York

Researchers at Binghamton University, State University of New York are working to understand the molecular composition of tattoo inks to provide knowledge to artists and consumers.

Released: 12-Oct-2022 5:00 PM EDT
Dermatologists Taking Action to Solve the Access to Care Conundrum
American Dermatological Association

The American Dermatological Association affirms the pressing need to address the defects that exist in the current medical infrastructure which prevent equal access, and consequently equitable medical outcomes, for all patients with dermatologic disorders. Issues limiting access to dermatology care are highlighted here and should urgently be addressed.

Released: 12-Oct-2022 10:25 AM EDT
Dermatologists warn people about the reliability of online symptom checkers
American Academy of Dermatology

Thanks to the internet, we have the world at our fingertips, and with just a few clicks, we can easily enter our medical symptoms into websites and apps to self-diagnose illnesses. However, a new article published in the Journal of the American Academy of Dermatology reveals that online symptom checkers are often inaccurate in identifying skin rashes.

Newswise: Scientists are One Step Closer to Stopping Drug-Resistant Tumors from Growing
Released: 11-Oct-2022 5:05 PM EDT
Scientists are One Step Closer to Stopping Drug-Resistant Tumors from Growing
University of Utah Health

Researchers at Huntsman Cancer Institute have solved a long-standing mystery about how a cancer-promoting protein causes drug-resistent tumors to grow. They hope the discovery leads to more effective cancer drugs. Ben Myers, PhD, explains how this new science is closing the gap in understanding brain and skin tumors and how to combat them.



close
2.26394